Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India
· Delayed Price · Currency is INR 168.27
-5.07 (-2.92%)
At close: Mar 9, 2026
Jagsonpal Pharmaceuticals Employees
Jagsonpal Pharmaceuticals had 1,399 employees as of March 31, 2025. The number of employees increased by 374 or 36.49% compared to the previous year.
Employees
1,399
Change (1Y)
374
Growth (1Y)
36.49%
Revenue / Employee
2.01M INR
Profits / Employee
292.37K INR
Market Cap
11.26B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1,399 | 374 | 36.49% |
| Mar 31, 2024 | 1,025 | 85 | 9.04% |
| Mar 31, 2023 | 940 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sakar Healthcare | 342 |
| Ind-Swift Laboratories | 1,246 |
| Beta Drugs | 399 |
| Windlas Biotech | 1,346 |
| Indoco Remedies | 6,000 |
| Sigachi Industries | 1,507 |
| Solara Active Pharma Sciences | 1,775 |
| Orchid Pharma | 736 |
Jagsonpal Pharmaceuticals News
- 6 weeks ago - Jagsonpal Pharmaceuticals Ltd (BOM:507789) Q3 2026 Earnings Call Highlights: Strategic Growth ... - GuruFocus
- 6 weeks ago - Q3 2026 Jagsonpal Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Q2 2026 Jagsonpal Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Jagsonpal Pharmaceuticals shares decline nearly 3% today as revenue and EBITDA soften in Q2 - Business Upturn
- 1 year ago - Jagsonpal Pharmaceuticals shares drop 2.6% after USFDA issues warning letter for manufacturing lapses at API plant - Business Upturn
- 1 year ago - Jagsonpal Pharmaceuticals acquires Resilient Cosmeceuticals’ India business for Rs 24 crore - Business Upturn
- 1 year ago - Jagsonpal Pharmaceuticals shares jump nearly 6% on strong Q3 FY25 results - Business Upturn
- 1 year ago - Jagsonpal Pharmaceuticals block trade: 22 lakh shares exchanged in ₹88 crore deal - Business Upturn